Literature DB >> 3496171

Stereospecific inhibition of cholinesterases by mefloquine enantiomers.

T L Ngiam, M L Go.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3496171     DOI： 10.1248/cpb.35.409

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  4 in total

1.  A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons.

Authors:  Robert Tansley; Julie Lotharius; Anthony Priestley; Fiona Bull; Stephan Duparc; Jörg Möhrle
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

2.  A high-performance liquid chromatographic method for the quantitative enantioselective analysis of mefloquine stereoisomers.

Authors:  Y Qiu; S Kitamura; J K Guillory
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

3.  Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine.

Authors:  A L Fontanet; B D Johnston; A M Walker; Y Bergqvist; U Hellgren; W Rooney
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

4.  Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.

Authors:  Sue J Lee; Feiko O Ter Kuile; Ric N Price; Christine Luxemburger; François Nosten
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.